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ABSTRACT 
Alzheimer’s disease (AD) is a progressive neurodegenerative disease that causes 
cognitive impairment, reduced functional status, and behavioral disturbances. As 
patients become increasingly impaired across these domains of functioning, they require 
greater assistance completing basic and instrumental activities of daily life. This 
assistance is overwhelmingly provided by informal caregivers. The adverse effects of 
increased AD severity on caregiver distress levels have been well documented in the 
literature. However, the reverse effects of baseline caregiver distress on future AD 
severity remain unknown. The present study used hierarchical linear regression to 
explore longitudinal downstream effects of baseline caregiver distress on cognitive and 
neuroanatomical indicators of AD severity. Analyses were completed using data from 
the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (N = 184). Results 
indicated that baseline caregiver distress predicted cognitive status at both 12 and 24 
months follow-up. Future research is needed to corroborate this finding, which may have 
significant clinical implications in regards to improving patient outcomes by alleviating 
caregiver distress. 
 
 
 
 
 
 
iii 
ACKNOWLEDGMENTS 
 
I would like to thank my committee chair, Dr. Balsis, and my committee 
members, Dr. Geraci and Dr. Radcliff, for their guidance throughout the course of this 
research. I would also like to thank the Alzheimer’s Disease Neuroimaging Initiative 
(ADNI) for providing the opportunity for collaboration. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iv 
CONTRIBUTORS AND FUNDING SOURCES 
 
Contributors  
This work was supported by a thesis committee consisting of Professor Steve 
Balsis (advisor) and Professor Lisa Geraci of the Department of Psychological and Brain 
Sciences and Professor Tiffany Radcliff of the Department of Health Policy & 
Management.  
The data analyzed for Chapter III were provided by the Alzheimer’s Disease 
Neuroimaging Initiative (ADNI). All other work conducted for the thesis was completed 
by the student, under the advisement of Professor Steve Balsis of the Department of 
Psychological and Brain Sciences.  
Funding Sources  
Graduate study was supported by a fellowship from the Office of Graduate and 
Professional Studies of Texas A&M University. 
 
 
 
 
 
 
 
 
v 
TABLE OF CONTENTS 
 
ABSTRACT ....................................................................................................................... ii 
ACKNOWLEDGMENTS ................................................................................................. iii 
CONTRIBUTORS AND FUNDING SOURCES ............................................................. iv 
TABLE OF CONTENTS ................................................................................................... v 
CHAPTER I INTRODUCTION AND LITERATURE REVIEW .................................... 1 
Alzheimer’s disease Epidemiology and Pathology ................................................ 1 
Caregiver Distress .................................................................................................. 2 
Effects of Neuropsychiatric Symptoms on Caregiver Distress .............................. 3 
Effects of Caregiver Distress on Alzheimer’s disease Severity ............................. 6 
Indicators of Alzheimer’s disease Severity ............................................................ 9 
Effects of Demographic Variables on Caregiver Distress.................................... 11 
Present Study ........................................................................................................ 12 
CHAPTER II METHODS ................................................................................................ 13 
Participants ........................................................................................................... 13 
Measures ............................................................................................................... 14 
Data Analyses ....................................................................................................... 17 
CHAPTER III RESULTS ................................................................................................ 20 
Sample Characteristics ......................................................................................... 20 
Neuropsychiatric Symptom Characteristics  ........................................................ 21 
Caregiver Distress Characteristics ....................................................................... 22 
Effects of Patient Demographics on Baseline Caregiver Distress  ...................... 24 
Effects of Baseline Caregiver Distress on Future Alzheimer’s disease 
Severity  ................................................................................................................ 25 
CHAPTER IV DISCUSSION .......................................................................................... 27 
CHAPTER V SUMMARY AND CONCLUSIONS ....................................................... 30 
REFERENCES ................................................................................................................. 31 
vi 
APPENDIX A .................................................................................................................. 40 
APPENDIX B .................................................................................................................. 42 
 
  
1 
CHAPTER I 
INTRODUCTION AND LITERATURE REVIEW 
Alzheimer’s disease Epidemiology and Pathology 
Alzheimer’s disease (AD) is a progressive neurodegenerative disease that causes 
cognitive impairment, reduced functional status, and behavioral disturbances. With the 
rapid growth of the older adult (65 years and older) population over the last fifty years, 
AD has become one of the most pressing health concerns in the United States. AD 
affects more than 5 million American adults, almost two thirds of whom are women 
(Alzheimer’s Association, 2016). A new case of AD is diagnosed approximately every 
66 seconds (Alzheimer’s Association, 2016), and it is currently the sixth leading cause of 
death in the United States (Alzheimer’s Association, 2016; Centers for Disease Control, 
2016).  
While the exact etiology of AD remains unknown, evidence suggests that AD 
pathology is linked to abnormal deposits of proteins in the brain. These protein deposits 
form amyloid plaques and neurofibrillary tau tangles in and around neurons (National 
Institutes on Aging, 2016). As previously healthy neurons become diseased, they cease 
functioning, lose synaptic connections with surrounding neurons, and die (National 
Institutes on Aging, 2016). Progressive neuronal death results in atrophy, or shrinkage, 
of vital brain structures, leading to impairments in processes regulated by those 
structures, including cognitive, behavior, emotional, and adaptive function.  
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Caregiver Distress 
As patients become increasingly impaired across these domains of functioning, 
they require greater assistance completing basic and instrumental activities of daily life. 
This assistance is overwhelmingly provided by informal caregivers, with more than 80% 
of long-term care for AD patients provided by informal caregivers (Alzheimer’s 
Association, 2016). Informal caregivers are family members and friends who provide 
daily help and support to individuals who are either temporarily or permanently unable 
to function independently (Los Angeles County Department of Public Health, 2010). 
There are currently more than 15 million caregivers for Americans with AD and other 
dementias (Alzheimer’s Association, 2016). 30% of dementia patients rely on three or 
more unpaid caregivers (Alzheimer’s Association, 2016), partially explaining the 3 to 1 
ratio of caregivers to patients. On a national scale, the time and financial costs of 
caregiving are astounding. In 2015, almost 16 million unpaid caregivers provided 
roughly 18 billion hours of care to patients with AD or other dementias, a contribution 
valued at more than $221 billion (Alzheimer’s Association, 2016).  
Looking more closely at the consequences of caregiver burden at an individual 
level, caregivers report significant financial burden related to their caregiving duties. 
Eighty-six percent of dementia caregivers have provided care and assistance for at least 
the past year, and caregivers of AD patients provide care for a longer time than do 
caregivers of older adults with other conditions (Alzheimer’s Association, 2016). 
Approximately 1 out of 4 caregivers spends at least 36 hours weekly caring for an AD 
patient (American Psychological Association, 2006), which equates to roughly 32% of 
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their total waking hours in a given week. Often, caregiving obligations take time away 
from work (Alzheimer’s Association, 2016), leading to lost wages and a decrease in 
income. Additionally, expenses directly related to care provision exceed an average of 
$5,000 annually per family (Alzheimer’s Association, 2016). This is a considerably 
concerning figure given that 41% of caregivers have a household income of $50,000 or 
less (Alzheimer’s Association, 2016).  
Caregivers are also affected by adverse physical and psychological health issues. 
Caregivers are at increased risk of developing symptoms of anxiety or depression 
(Mahoney, Regan, Katona, & Livingston, 2006) and report increased physical ailments 
(Roth, Haley, Owen, Clay, & Goode, 2001; Vitaliano, Zhang, & Scanlan, 2003), poorer 
immune status (Fredman et al., 2008), and reduced health-related quality of life 
(Serrano-Aguilar, Lopez-Bastida, & Yanes-Lopez, 2006), relative to non-caregivers. 
Caregivers may also be at an elevated risk for all-cause mortality (Perkins et al., 2012; 
Talley & Crews, 2007). Thirty-four percent of caregivers are over the age of 65 
(Alzheimer’s Association, 2016) and are at an increased risk for the aforementioned 
health related issues due to their advanced age. 
Effects of Neuropsychiatric Symptoms on Caregiver Distress 
While caregivers of AD patients often report elevated levels of general distress 
(Alzheimer’s Association, 2016),  they are often particularly distressed by 
neuropsychiatric symptoms  (Kaufer et al., 1998), perhaps even more than they are by 
cognitive impairments (Fauth & Gibbons, 2014; Fuh, Liu, Mega, Wang, & Cummings, 
2001). Neuropsychiatric symptoms commonly observed among AD patients can be 
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generally grouped into three categories: behavioral disturbances, psychosis symptoms, 
and affective symptoms. Behavioral disturbances include aberrant motor behavior, 
changes in appetite, and sleep disturbances/nighttime behaviors. Psychosis primarily 
consists of hallucinations and delusions. Affective symptoms include feelings of 
depression, anxiety, and apathy.  
Patients may present with different constellations of symptoms, based on 
comorbid conditions and their stage in the disease process. For example, symptoms of 
depression and anxiety have been reported to be predictive of conversion from mild 
cognitive impairment to AD (Gallagher et al., 2011; Palmer et al., 2007), while 
hallucinations and delusions are more likely to be observed at a higher level of AD 
severity (Fuller, Choudhury, Lowe, & Balsis, 2016).  Estimated prevalence rates of 
individual neuropsychiatric symptoms within the AD population vary, but evidence 
suggests that symptoms of apathy or indifference are some of the most frequently 
reported (Fauth & Gibbons, 2014; Kaufman et al., 1998; Mega, Cummings, Fiorello, & 
Gornbein, 1996). Agitation, anxiety, and irritability (Fauth & Gibbons, 2014; Mega, 
Cummings, Fiorello, & Gornbein, 1996) are also commonly observed neuropsychiatric 
symptoms among AD patients.  
There are many factors that influence which neuropsychiatric symptoms are most 
distressing and why. While symptoms of apathy and agitation are often cited as two of 
the most frequently observed symptoms in AD patients, these symptoms are not 
necessarily described as the most distressing. As such, the relationship between 
frequency of symptom presentation and resulting distress remains unclear (Fauth & 
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Gibbons, 2014; Mioshi, Bristow, Cook, & Hodges, 2009). Research suggests that while 
frequently observed neuropsychiatric symptoms, such as symptoms of apathy and 
anxiety, are often very distressing to caregivers (Fuh, Liu, Mega, Wang, & Cummings, 
2001; de Vugt et al., 2006), some of the most distressing neuropsychiatric symptoms are 
less frequently observed, such as  delusions (Fauth & Gibbons, 2014; Fuh, Liu, Mega, 
Wang, & Cummings, 2001). Frustration or distress related to neuropsychiatric symptoms 
may also vary as the disease progresses, with higher levels of distress often observed at 
onset and lower levels observed as the disease continues (Motenko, 1989), despite the 
likelihood of neuropsychiatric symptoms increasing as the disease progresses and 
cognition declines (Ricci et al., 2009).  In sum, caregiver distress may arise differentially 
across symptoms and stages of AD severity.  
Research on patients’ neuropsychiatric symptoms and resulting caregiver distress 
has often included use of the Neuropsychiatric Inventory (NPI; Cummings, 1997), one 
of the most commonly used measures of neuropsychiatric symptoms in both clinical and 
research settings with documented reliability and validity (Cummings et al., 1994; 
Cummings, 1997). The NPI is a clinician-administered structured interview protocol that 
assesses the presence, frequency, and severity of 12 neuropsychiatric symptoms: 
delusions, hallucinations, agitation/aggression, depression/dysphoria, anxiety, 
elation/euphoria, apathy/indifference, disinhibition, irritability/lability, aberrant motor 
behavior, nighttime behaviors, and appetite/eating. In addition to evaluating the 
symptoms themselves, caregivers are asked to rate their subjective levels of distress in 
response to those symptoms, from “not at all” to “very severely or extremely” 
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distressing. It is important to note that the NPI prompts respondents to consider their 
distress in response to the designated neuropsychiatric symptoms specifically, rather 
than their global distress in response to the disease overall. 
The relationship between patients’ neuropsychiatric symptoms and caregiver 
distress has been studied frequently using the NPI and is well documented in the 
literature (Clyburn, Stones, Hadjistavropoulos, & Tuokko, 2000; Craig, Mirakhur, Hart, 
McIlroy, & Passmore, 2005; Kaufer et al., 1998). As neuropsychiatric symptoms worsen 
in concordance with increasing AD severity, caregiver distress also increases. These 
findings have highlighted the importance of pharmacological treatment of 
neuropsychiatric symptoms as well as psychoeducational interventions to prepare 
caregivers, with the primary goal of alleviating distress. Interestingly, there is currently 
little to no examination of the impact of caregiver distress on AD severity. Specifically, 
neuropsychiatric symptoms are shown to have an effect on caregiver distress, which may 
in turn have downstream effects on other of AD severity, such as cognitive impairment 
and neurodegeneration.  
Effects of Caregiver Distress on Alzheimer’s disease Severity 
 If indeed increased caregiver distress contributes to increased AD severity, as 
reflected by changes in cognitive or neuroanatomical indicators, this phenomenon may 
be partially attributable to the close nature of the caregiver/patient relationship, the 
importance of which is undisputed. Caregivers often play a prominent role, if not the 
only role, in an AD patient’s life. As such, the relationship between patient and caregiver 
is especially intimate and important. After prolonged contact and interaction, patients’ 
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neuropsychiatric symptoms become troublesome for caregivers. Conversely, emotional 
distress in caregivers may have a more salient adverse effect on patient functioning 
(presumably due to increased AD severity).  Increased AD severity may then lead to 
increased neuropsychiatric symptoms which then lead to increased caregiver distress, 
creating a cycle of increasingly troublesome caregiver distress and patient AD severity. 
If this cyclical relationship exists, then the motivation for treating neuropsychiatric 
symptoms and educating caregivers goes beyond simply alleviating caregiver distress.  
Treating neuropsychiatric symptoms, which may in turn result in reduced caregiver 
distress, may contribute to slower, even if minimally, disease progression. Before this 
cyclical relationship can be established, however, we must first establish that caregiver 
distress indeed has downstream effects on cognitive or neuroanatomical aspects of AD 
severity in the early stage of the disease. 
Various animal and human subjects studies have shown that long-term or chronic 
stress can result in damage to areas of the brain such as the hippocampus (Bremner, 
1999; Carrion, Weems, & Reiss, 2007; Frodl & O’Keane, 2013), one of the primary 
structures affected in early AD. In these studies, hippocampal volume reduction was 
documented with magnetic resonance imaging (MRI) data and inferred from deficient 
performance on neuropsychological measures reflective of hippocampal function 
(Bremner, 1999; Carrion et al., 2007; Frodl & O’Keane, 2013). Evidence suggests that 
hippocampal damage is mediated through neurotoxicity secondary to increased cortisol 
exposure and possible neuroinflammation, a theory known as the glucocorticoid cascade 
hypothesis (Frodl & O’Keane, 2013; Sapolsky, Krey, & McEwen, 1986). While the 
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hypothesized mechanism through which hippocampal damage is inflicted is complex, 
findings from studies in this area have been robust and consistent.  
In addition to chronic stress, various anxiety-related and depressive disorders 
have been associated with adverse changes in both anatomy and physiology of the 
hippocampus as well as other areas, such as the amygdala and the prefrontal cortex 
(Lupien, McEwen, Gunnar, & Herim, 2009; McEwen, 2007). These disorders include 
posttraumatic stress disorder (Bremner, 2002) and major depressive disorder 
(Rajkowska, 2000; Sheline, Gado, & Price, 1998; Stockmeier et al., 2004).   
Presently, this area of literature has focused on intrapersonal processes; 
specifically, the same individual who has experienced intense stress demonstrates 
hippocampal volumetric and functional deficits. Extending this methodology, one may 
consider interpersonal processes and examine the possible effects of intense stress 
experienced external to the individual. That is to say, can stress (or relatedly, anxious or 
depressed mood) experienced by someone in an individual’s environment have similar 
effects on his or her brain? If so, then caregiver of AD patients, who are known to be at 
elevated risk of experiencing frequent and severe bouts of stress and poor mood, may be 
inadvertently negatively affecting their loved ones at a molecular level. 
If caregiver distress can be considered as a potential aggravator of AD severity, 
then caregiver contentment can be considered as a potential protective factor against 
disease progression. Caregivers who are relatively less chronically distressed are 
presumably more able to maintain a strong, positive relationship with their patients. A 
healthy caregiver-patient relationship can be a significant asset for AD patients, who, as 
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stated previously, often have very few meaningful social connections left as the disease 
progresses. While a fractious caregiver-patient relationship may qualify as a 
psychosocial risk factor for adverse health outcomes (Heinrichs, Baumgartner, 
Kirschbaum, & Ehlert, 2003), a strong caregiver-patient relationship can promote social 
support and reduce loneliness for the patient, both of which have been documented as 
protective factors across a wide variety of diagnoses (Heinrichs et al., 2003; McEwen, 
2007). When considering AD specifically, a handful of studies have found that social 
connectedness is a protective factor against incidence of dementia (Fratiglioni, Hui-Xin, 
Ericsson, Maytan, & Winblad, 2000) and cognitive dysfunction secondary to AD 
pathology (Bennett, Schneider, Tang, Arnold, & Wilson, 2006). In sum, the nature of the 
caregiver-patient relationship, impacted substantially by caregiver distress, may result in 
subtle but meaningful changes in an AD patient’s disease severity.  
Indicators of Alzheimer’s disease Severity 
Because AD is a multifaceted disease that affects an individual at the anatomical, 
physiological, and functional levels, AD severity cannot simply be operationalized as 
change in one particular variable or be represented by one indicator alone. Furthermore, 
changes observed in certain indicators (namely, cognitive functioning and 
neuropsychiatric symptoms) may be attributable to etiological factors other than AD 
pathology or may simply be typical of normal aging. For example, cognitive change 
associated with normal aging has been well documented in the literature (Erickson & 
Barnes, 2003; Harada, Love, & Triebel, 2013) and is observed in individuals who never 
go on to develop AD. Cognitive decline is also associated with separate psychiatric and 
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medical conditions, including depression (Rodda, Walker, & Carter, 2011) and various 
vascular conditions (Gorelick et al., 2011). Neuropsychiatric symptoms such as changes 
in mood, appetite, and sleep may be caused by a psychiatric condition, such as 
depression (Fiske, Wetherell, & Gatz, 2009; Rodda, Walker, & Carter, 2011), or 
hormonal changes, such as those related to menopause (Lamberts, van den Beld, & van 
der Lely, 1997). Certain neuroanatomical changes, such as volume loss, are also 
associated with normal aging (Raz et al., 2011; Scahill et al., 2003). However, 
accelerated atrophy within the temporal lobe is associated with dementing conditions, 
such as AD, specifically (Chan et al., 2001; Jack et al., 1998). 
To account for the multiple types of impairment that characterize AD and 
address possible confounding causes of those impairments, AD severity is often 
operationalized across multiple domains of AD-associated symptoms within one study. 
Specifically, global cognitive decline and neurodegeneration are two domains that are 
documented in the literature as being associated with or related to AD pathology (Balsis 
et al., 2016; Jack et al., 2010; 2013) and capture unique aspects of the disease process. 
Cognitive decline is apparent in AD patients but not exclusively associated with AD 
pathology. Including measures of neurodegeneration will allow for a stronger causal link 
to be established between present caregiver distress and future AD severity. 
Additionally, by examining the possible relationship between caregiver distress and each 
of different AD severity domains, we may be able to ascertain if caregiver distress 
affects each domain differentially. More specifically, current caregiver distress may be 
more strongly associated with future cognitive decline than with neurodegeneration.  
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Effects of Demographic Variables on Caregiver Distress 
Caregiver distress may vary in response to variations in symptoms or AD 
severity, but it may also be affected by demographic variables, such as caregiver gender, 
as well as the nature of the relationship between the caregiver and the patient. 
Approximately two thirds of caregivers are women (Alzheimer’s Association, 2014; 
Kasper, Freedman, & Spillman, 2014); more specifically, over one third of dementia 
caregivers are daughters (Langa et al., 2005). More than half of caregivers take care of 
one or both parents (Fisher et al., 2011), but this is not limited to adults. As many as 
250,000 children and adolescents between 8 and 18-years-old provide help to an AD 
patient (National Alliance for Caregiving & United Hospital Fund, 2005). In regards to 
spousal care, it is more common for wives to provide informal care for a husband than 
vice versa (National Alliance for Caregiving & AARP, 2009). Collectively, whether the 
caregiver is a spouse or child, female caregivers (i.e. wives and daughters) are more 
likely to experience higher levels of burden and distress related to caregiving than their 
male counterparts (Alzheimer’s Association, 2016; Lutzky & Knight, 1994). Despite the 
availability of epidemiological data to characterize the population of caregivers and 
identify possible factors in caregiver distress, the exact mechanism of distress onset or 
exacerbation remains unknown. Examining variance in caregiver distress across 
different types of caregivers (for example, spouse versus child) may reveal groups of 
caregivers who are more vulnerable to subjective distress and therefore require tailored 
preparation or intervention. 
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Present Study 
Through this study, we sought to take the first steps towards understanding the 
possible adverse effects of caregiver distress on patient AD severity, which may have 
several important research and clinical implications. To do this, we first examined the 
effects of patient demographic variables on caregiver distress to determine which, if any, 
variables should be statistically controlled for subsequent analyses. Second, we 
determined if baseline caregiver distress had downstream effects on future cognitive or 
neuroanatomical indicators of AD severity, controlling for baseline cognitive status and 
neuroanatomical volumes. Given these aims, we hypothesized that the patient’s gender, 
baseline diagnosis, and education level would have an effect on caregiver distress. We 
also hypothesized that baseline caregiver distress would account for unique variance in 
future AD severity, controlling for baseline cognitive status and neuroanatomical 
volumes.  
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CHAPTER II 
METHODS 
Data used in the preparation of this study was obtained from the Alzheimer’s 
Disease Neuroimaging Initiative (ADNI) database, adni.loni.usc.edu. The ADNI was 
launched in 2003 as a public-private partnership. The initial goal of ADNI was to recruit 
800 participants but ADNI has been followed by two other initiatives, ADNI-GO and 
ADNI-2. To date these three protocols have recruited over 1500 adults, ages 55 to 90, to 
participate in the research. The sample consists of older adults who are cognitively 
healthy, those with early or late mild cognitive impairment (MCI), and those with early 
AD. Demographic information and clinical data used for this study were downloaded 
from the ADNI data repository (adni.loni.usc.edu) on May 28, 2014. Data for the current 
analyses came from individuals who completed baseline and follow-up assessments and 
had complete data for key neuropsychiatric, cognitive, and MRI variables described 
below.  
Participants 
Sample Selection 
The analyses for the present study used data from baseline, 12, and 24-months 
follow-up from participants enrolled across all three ADNI phases. The effects of 
caregiver distress on cognitive or neuroanatomical indicators of AD severity may not be 
immediately detectable by statistical analysis. As such, using data from 12 and 24 
months follow-up us to examine changes in outcome data over time and detect subtle 
effects. Demographic data, including age, gender, education level, race, and marital 
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status were mined for each participant. Baseline diagnosis was also recorded. In this 
dataset, baseline diagnoses represented a range of cognitive impairment, from 
cognitively normal through mild cognitive impairment (MCI) to presumed mild AD. 
Cognitively normal participants were included to capture potential conversion from 
baseline to 12 months follow-up, thereby reflecting the continuum of normal aging to 
dementia. In the ADNI, cognitively normal participants serve as the controls and show 
no signs of MCI or dementia.  
Participants were excluded from the analyses if they had a premorbid history of 
significant neurologic disease (including multi-infarct dementia and subdural 
hematoma), as well as various neuropsychiatric disorders such as major depressive 
disorder, schizophrenia, and bipolar disorder. Participants were also excluded based on 
absent or incomplete baseline or follow-up data. After an iterative procedure of 
eliminating cases with absent or incomplete data, the final sample size was N = 184. 
Measures 
AD severity was operationalized across two categories of AD-associated 
symptoms: global cognitive decline and neurodegeneration. To characterize global 
cognitive status, ADNI participants were given the Alzheimer’s Disease Assessment 
Scale (ADAS-cog; Mohs & Cohen, 1988). Structural MRI scans were used to assess 
volume of the whole brain as well as cortical volumes of three temporal lobe regions: the 
entorhinal cortex, hippocampus, and middle temporal gyrus. Together, these measures 
were used to operationalize AD severity. The Neuropsychiatric Inventory (NPI; 
Cummings, 1997) was used to asses for frequency and severity of neuropsychiatric 
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symptoms, as well as caregiver distress in response to those symptoms. For this study, 
we used data from baseline (0 months), 12, and 24 months follow-up. The procedures 
used for each of these domains are briefly described below (full description online at 
adni.loni.usc.edu). 
Global Cognitive Status  
Neuropsychological measures of screening and staging are commonly used in 
clinical research to characterize global cognitive status. One of the clinician-
administered measures used in the ADNI is the Alzheimer’s Disease Assessment Scale 
(ADAS-cog; Mohs & Cohen, 1988). While additional cognitive screening and staging 
measures are given to ADNI participants, such as the Mini Mental State Examination 
(MMSE; Folstein, Folstein, & McHugh, 1975), we only used the ADAS-cog for this 
study. The ADAS-cog is more specific to AD-related cognitive impairment, while the 
MMSE is not disorder-specific. Additionally, the ADAS-cog is scored out of 70 points, 
as opposed to the 30-point scale used on the MMSE. This allowed for increased 
measurement precision that reflected wider variability in performance on the ADAS-cog 
and consequently more accurate characterization of participants’ cognitive status.  The 
ADAS-cog consists of 11 tasks measuring disturbances of memory, language, praxis, 
and attention. ADAS-cog scores are reported as errors made out of 70 points total (i.e. 
higher scores correspond to more compromised cognitive status). 
MRI Volume. 
Structural MRI scans enable volumetric measurements of the entire brain as well 
as specific neuroanatomical regions, which can indicate patterns of volumetric changes 
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and brain atrophy associated with AD. This study examined MRI volumes (cubic 
millimeters) of the whole brain and three temporal lobe brain sub-regions implicated in 
the neurodegenerative component of AD pathology: the entorhinal cortex, hippocampus, 
and the middle temporal gyrus. All MRI volumes were corrected for variance due to 
participant age and gender using linear regression. MRI volumes for the three sub-
regions were also corrected for intracranial volume. The residual values that were 
derived from the regression analyses were used for all subsequent analyses.  
Neuropsychiatric Symptoms 
The NPI (Cummings, 1997) was administered to caregivers to assess the 
presence, frequency, and severity of 12 neuropsychiatric symptoms: delusions, 
hallucinations, agitation/aggression, depression/dysphoria, anxiety, elation/euphoria, 
apathy/indifference, disinhibition, irritability/lability, aberrant motor behavior, nighttime 
behaviors, and appetite/eating. Presence is scored on a binary scale (“yes” or “no”). 
Frequency is rated on a four-point scale as follows: 1 for “rarely”, 2 for “sometimes”, 3 
for “often”, and 4 for “very often”. Severity is rated on a three-point scale as follows: 1 
for “mild”, 2 for “moderate”, and 3 for “severe”. Tables 1a and 1b illustrate the rating 
schemas, including operational definitions, for both frequency and severity. A total NPI 
score can be calculated by adding the frequency and severity ratings together for all 
endorsed symptoms (Cummings, 1997). 
Caregiver Distress 
The NPI (Cummings, 1997) was also administered to caregivers to assess 
subjective levels of distress in response to neuropsychiatric symptoms. Caregivers were 
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asked to rate their own distress levels on a six-point scale as follows: 0 for “not at all”, 1 
for “minimally distressing”, 2 for “mildly distressing”, 3 for “moderately distressing”, 4 
for “severely distressing”, and 5 for “very severely or extremely distressing”. Table 1c 
illustrates the rating schema, including operational definitions, for caregiver distress. For 
this study, we calculated a total caregiver distress score by summing distress ratings 
across all endorsed symptoms in order to capture variance in both intensity and breath of 
caregiver distress. While the total distress metric is described by Cummings as part of 
the repertoire of results that can be derived from the NPI (1997), these values were not 
listed in the ADNI database and therefore were calculated manually during the data 
analysis phase.   
Data Analyses 
SPSS Statistics 22.0 (IBM, 2013) was used to perform all analyses in this study. 
To characterize the sample of patients, we generated descriptive statistics (means and 
standard deviations) and frequencies for baseline data for the six demographic/clinical 
variables: age, gender, education level, race, marital status, and baseline diagnosis. 
Sample characteristics are described in greater detail in the Results section. Descriptive 
statistics for NPI results were also generated, including frequencies of endorsed 
symptoms and mean severity and caregiver distress ratings across symptoms. Repeated 
measures analysis of variance (ANOVA) was used to determine if sample characteristics 
for NPI results differed significantly across time points. 
In the next part of the analyses, we used one-way ANOVA to examine the effects 
of categorical participant demographic variables on baseline caregiver distress (gender, 
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race, marital status, and baseline diagnosis), using p < 0.05 as the significance threshold. 
Pearson product-moment correlation coefficients (Pearson’s r) were generated between 
the continuous participant demographic variables (age, education level, baseline residual 
neuroanatomical volumes, and baseline ADAS-cog score) and baseline caregiver 
distress. We again used p < 0.05 as the significance threshold. The results of these initial 
analyses were used to determine which, if any, demographic variables must be 
controlled for in subsequent analyses. 
The third part of the analyses featured hierarchical linear regression to examine 
the effects of baseline caregiver distress on future AD severity. Categorical demographic 
variables (gender, marital status, race, and baseline diagnosis) were dummy coded using 
zeroes and ones prior to this phase of the analyses. Each regression model consisted of 
seven steps. In the first four steps of the regression, we entered only demographic 
variables (age, gender, education level, marital status, race, and baseline diagnosis) to 
control for their effects on future AD severity. Specifically, age, gender, and education 
level were entered in step one. Baseline diagnosis (dummy coded) was entered in step 
two. Race (dummy coded) was entered in step three, and marital status (dummy coded) 
was entered in step four. In the fifth and sixth steps of the model, we entered baseline 
ADAS-cog score and baseline residual neuroanatomical volumes as predictor variables, 
respectively. In the seventh and final step, we entered baseline caregiver distress in 
response to all endorsed neuropsychiatric symptoms as a predictor variable to determine 
if it accounted for unique variance above and beyond the previously entered predictors. 
Figure 1 graphically illustrates the structure of this section of the regression analyses.  
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Within this phase of the analyses, the outcome variable was changed to reflect 
the two operational definitions of AD severity used in this study: cognitive dysfunction 
(ADAS-cog score) and neurodegeneration (whole brain and temporal lobe volumes). 
Figure 2 illustrates the final step of each model with the outcome variable changed. As 
each hierarchical regression consisted of 7 steps, this phase of the analyses ultimately 
featured 35 regression equations in total (7 steps per hierarchical regression x 5 
operational definitions of AD severity). Both models (cognitive dysfunction and 
neurodegeneration as outcome variables) were replicated using data from 24 months 
follow-up in addition to 12 months follow-up, as illustrated in Figure 3. Consequently, 
we derived 35 additional regression equations divided into 5 models. In total, we 
generated 70 regression equations divided into 10 models, as illustrated in Figure 4. 
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CHAPTER III 
RESULTS 
Sample Characteristics 
The analyses for the present study used baseline data from 184 participants (87 
female, 47%) enrolled across all three ADNI phases. At baseline, participants were an 
average of 71.63 years old (SD = 6.82), with ages ranging from 55 to 90. Participants 
were also highly educated (M = 16.49, SD = 2.58 years), with all participants having 
completed at least the 11th grade. The majority identified their race as white (n = 175, 
95%); other races represented included black or African American (n = 6, 3%), Asian (n 
= 2, 1%), and Hawaiian/Pacific Islander (n = 1, 0.5%). In regards to marital status, the 
majority of participants were married at the time of the baseline assessment (n = 139, 
76%). 17 (9%) were widowed, 24 (13%) were divorced, and 4 (2%) were never married.  
Baseline diagnoses represented a range of cognitive impairment: 73 (40%) were 
cognitively normal and 103 (56%) had MCI. Eight participants (4%) had presumed 
Alzheimer’s dementia at baseline. We included the cognitively normal (CN) participants 
in order to capture possible conversion in diagnostic status over the course of the 
analyses. Mean total NPI score was 3.32 (SD = 6.21), and mean caregiver distress rating 
across the 12 neuropsychiatric symptoms assessed was 0.17 (SD = 0.28). Mean ADAS-
Cog score was 8.43 (SD = 4.60). Residual values for MRI volumes ranged from -
242462.23 mm3 to 206685.68 mm3 for the whole brain. Residual values for MRI 
volumes of temporal lobe sub-regions ranged from -2089.36 mm3 to 2122.12 mm3 for 
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the hippocampus, -2197.50 mm3 to 2072.57 mm3 for the entorhinal cortex, and -7668.04 
mm3 to 6174.58 mm3 for the middle temporal gyrus.  
Neuropsychiatric Symptom Characteristics   
Neuropsychiatric symptoms and associated caregiver distress were characterized 
for the sample at baseline, 12 months, and 24 months follow-up. At baseline, the mean 
total NPI score was 3.32 (SD = 6.21). At 12 months follow-up, the mean total NPI score 
was 3.86 (SD = 6.60), and at 24 months follow-up, the mean total NPI score was 5.44 
(SD = 9.56). At baseline, the highest observed total NPI score was 43. At 12 months 
follow-up, the highest observed total NPI score was 47, and at 24 months follow-up, the 
highest observed total NPI score was 61, 18 points greater than the highest observed 
score at baseline. Repeated measures ANOVA was used to compare mean total NPI 
score across baseline, 12 months, and 24 months follow-up. Mean total NPI score at 
baseline was significantly different from mean total NPI score at 24 months follow-up (p 
< 0.05). Mean total NPI score at 12 months follow-up was also significantly different 
from mean total NPI score at 24 months follow-up (p < 0.05). Figure 5 illustrates the 
marginal means for mean total NPI score from baseline through 24 months follow-up for 
the entire sample. 
In regards to symptom frequency, most frequently endorsed symptom at baseline 
was depression/dysphoria (N = 36, 20%), followed by irritability/lability (N = 34, 19%), 
and sleep disturbance (N = 32, 17%). All neuropsychiatric symptoms were endorsed by 
at least one caregiver at baseline.  At 12 months follow-up, the most frequently endorsed 
symptom was irritability/lability (N = 37, 20%), followed by depression/dysphoria (N = 
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36, 20%) and sleep disturbance (N = 36, 20%). All neuropsychiatric symptoms were 
endorsed by at least one caregiver at 12 months follow-up. At 24 months follow-up, the 
most frequently endorsed symptom was irritability/lability (N = 42, 23%), followed by 
depression/dysphoria (N = 38, 21%), and apathy/indifference (N = 36, 20%). Again, all 
neuropsychiatric symptoms were endorsed by at least one caregiver at 24 months follow-
up. Figures 6a and 6b illustrate the distribution of symptom endorsement from baseline 
through 12 and 24 months follow-up for the entire sample.  
Average symptom severity rating varied from 0.13 (SD = 0.21) at baseline to 
0.14 (SD = 0.20) at 12 months and 0.17 (SD = 0.27) at 24 months follow-up for the 
entire sample. At baseline, 3 symptoms were rated by at least one caregiver as markedly 
severe: delusions, sleep disturbance, and disordered appetite/eating. At 12 months 
follow-up, 5 symptoms were rated by at least one caregiver as markedly severe: anxiety, 
disinhibition, irritability/lability, sleep disturbance, and disordered appetite/eating. At 24 
months follow-up, 8 symptoms were rated by at least one caregiver as markedly severe: 
delusions, agitation/aggression, depression/dysphoria, anxiety, disinhibition, 
irritability/lability, aberrant motor behavior, and sleep disturbance. Figures 7a and 7b 
illustrate the distribution of severity ratings per symptom from baseline through 12 and 
24 months follow-up for only those caregivers who endorsed the presence of a symptom 
to begin with.  
Caregiver Distress Characteristics 
In regards to caregiver distress related to neuropsychiatric symptoms, average 
distress ratings varied from 0.17 (SD = 0.28) at baseline to 0.18 (SD = 0.30) at 12 
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months and 0.24 (SD = 0.42) at 24 months follow-up for the entire sample. At baseline, 
three symptoms were described by at least one caregiver as very severely or extremely 
distressing: anxiety, sleep disturbance, and disordered appetite/eating. At 12 months 
follow-up, none of the symptoms were described as very severely or extremely 
distressing. At 24 months follow-up, a different set of three symptoms were described by 
at least one caregiver as very severely or extremely distressing: agitation/aggression, 
depression/dysphoria, and irritability/lability. Figures 8a and 8b illustrates the 
distribution of caregiver distress ratings per symptom from baseline through 12 and 24 
months follow-up for only those caregivers who endorsed the presence of a symptom to 
begin with. 
In addition to mean distress ratings, total distress ratings across symptoms were 
calculated by summing individual distress ratings for each symptom per caregiver. 
Higher total distress ratings corresponded to greater numbers of symptoms rated as 
distressing. In other words, a mean distress rating of 3 could be derived from simply one 
response (i.e. “Symptom A elicits a distress rating of 3; no other symptoms are 
distressing.”) or from three responses (i.e. “Symptom A elicits a distress rating of 2, 
Symptom B elicits a distress rating of 3, and Symptom C elicits a distress rating of 4.”). 
While both caregivers would receive a mean rating score of 3, the second caregiver was 
clearly distressed by a larger number of symptoms than was the first. Hence, total 
distress rating values were calculated to capture additional variance in breadth of 
distress.  
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At baseline, the mean total distress rating score was 1.99 (SD = 3.37). At 12 
months follow-up, the mean total distress rating score was 2.16 (SD = 3.57), and at 24 
months follow-up, the mean total distress rating score was 2.86 (SD = 5.00). At baseline, 
the highest observed total distress rating score was 17. At 12 months follow-up, the 
highest observed total distress rating score was 24, and at 24 months follow-up, the 
highest observed total distress rating score was 25, 8 points greater than the highest 
observed score at baseline. Repeated measures ANOVA was again used to compare 
mean total distress scores across baseline, 12 months, and 24 months follow-up. Mean 
total distress score at baseline was significantly different from mean total distress score 
at 24 months follow-up (p < 0.05). Mean total distress score at 12 months follow-up was 
also significantly different from mean total distress score at 24 months follow-up (p < 
0.05). Figure 9 illustrates the marginal means for mean total distress score from baseline 
through 24 months follow-up for the entire sample. 
Effects of Patient Demographics on Baseline Caregiver Distress  
Pearson product-moment correlation coefficients (Pearson’s r) were generated 
between continuous patient demographic variables (age, education level, baseline 
residual temporal lobe volumes, and baseline ADAS-cog score) and baseline caregiver 
distress. The correlation between patient’s age and baseline caregiver distress was r = -
0.03 (p > 0.05), and the correlation between patient’s education level and baseline 
caregiver distress was r = -0.18 (p < 0.05). The correlation between baseline residual 
whole brain volume and baseline caregiver distress was r = -0.13 (p > 0.05).The 
correlation between baseline residual hippocampus volume and baseline caregiver 
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distress was r = -0.10 (p > 0.05). The correlation between baseline residual entorhinal 
cortex volume and baseline caregiver distress was r = -0.13 (p > 0.05), and the 
correlation between residual middle temporal gyrus volume and baseline caregiver 
distress was r = -0.04 (p > 0.05). The correlation between baseline ADAS-cog score and 
baseline caregiver distress was r = 0.21 (p < 0.05). Table 2 lists Pearson’s r values and p-
values for the correlations described above. 
 One-way analysis of variance (ANOVA) was used to examine the effects of 
categorical patient demographic variables (gender, marital status, race, and baseline 
diagnosis) on baseline caregiver distress. Patient race and baseline diagnosis were found 
to significantly affect baseline caregiver distress (p < 0.05); the remaining variables were 
found not to significantly affect baseline caregiver distress. Post hoc comparisons using 
the Tukey Honestly Significant Different (HSD) test revealed that baseline caregiver 
distress was significantly lower for caregivers of cognitively normal patients compared 
to caregivers of patients with mild cognitive impairment or AD. Post hoc comparisons 
could not be conducted for patient race because one category (Hawaiian/Pacific Islander) 
consisted of only 1 participant. Table 3 lists F statistics and p-values for the four one-
way ANOVA analyses described above. 
Effects of Baseline Caregiver Distress on Future Alzheimer’s disease Severity 
 Hierarchical linear regression was used to examine the effects of baseline 
caregiver distress on cognitive and neuroanatomical indicators of AD severity. Entering 
baseline caregiver distress as a predictor significantly improved the model when ADAS-
cog score was used as the outcome variable for both 12 months and 24 months follow-up 
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(p < 0.05), suggesting that variance in baseline caregiver distress does account for 
variance in future cognitive dysfunction. Significant results at both 12 and 24 months 
follow-up suggest that this effect does hold over time. Entering baseline caregiver 
distress as a predictor did not significantly improve the model when residual whole brain 
or temporal lobe volumes were used as the outcome variables for neither 12 months nor 
24 months follow-up. However, results did trend towards significance when comparing 
12 months to 24 months follow-up. Consequently, it may be that effects on future 
neuroanatomical atrophy do arise as a result of baseline caregiver distress, but these 
effects may be extremely subtle and manifest at a much slower rate. Results of the 
regression analyses are presented in Tables 4a through 4j. 
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CHAPTER IV 
DISCUSSION 
The purpose of this study was to take the first steps towards understanding the 
possible adverse effects of caregiver distress on patient AD severity. Results indicated 
that entering baseline caregiver distress as a predictor significantly improved the model 
when ADAS-cog score was used as the outcome variable for both 12 months and 24 
months follow-up, suggesting that variance in baseline caregiver distress does account 
for variance in future cognitive dysfunction. Significant results at both 12 and 24 months 
follow-up suggest that this effect does hold over time. Entering baseline caregiver 
distress as a predictor did not significantly improve the model when residual whole brain 
on temporal lobe volumes were used as the outcome variables for neither 12 months nor 
24 months follow-up. However, results did trend towards significance, as indicate by 
considerable declines in p-values, when comparing 12 months to 24 months follow-up. 
Consequently, it may be that effects on future neuroanatomical atrophy do arise as a 
result of baseline caregiver distress, but these effects may be extremely subtle and 
manifest at a much slower rate.  
The mechanism through which baseline caregiver distress in response to 
neuropsychiatric symptoms predicts future cognitive status (as characterized by ADAS-
cog scores) is unclear. Based on preliminary findings discussed previously in the 
introduction, it may be the case that increased caregiver distress leads to reduced social 
connectedness, which has been found to be a protective factor against incidence of 
dementia (Fratiglioni et al., 2000) and cognitive dysfunction secondary to AD pathology 
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(Bennett et al., 2006). Alternatively, caregiver distress may compromise the quality of 
care that an AD patient receives, which may facilitate faster decline. For example, 
caregivers who become increasingly distressed without adequate tools to manage their 
distress may become despondent or detached. This in turn may reduce the degree of 
interpersonal connectedness (described above) between caregiver and patient. 
Furthermore, it may increase feelings of distress in the patient, which in turn may result 
in impaired cognitive function.  
While we did not encounter significant effects for predicting future residual 
temporal lobe volumes from baseline caregiver distress, our results did trend towards 
significance when comparing 12 months to 24 months follow-up. This trend is 
noteworthy as it suggests that prolonged longitudinal follow-up of patients may reveal 
that baseline caregiver distress does in fact impact neuroanatomy over time, albeit very 
slowly and minimally. Nonetheless, such a finding may have meaningful clinical 
implications, including diagnosis and treatment planning, but further investigation of this 
potential effect is needed. 
While these preliminary findings are intriguing, limitations of this study (largely 
based in data availability and design) likely impacted the results. First, a larger sample 
size would have increased our power in detecting a statistically significant effect. Our 
small sample size (N = 184) was derived after eliminating participants for whom there 
was missing or incomplete key data across the three time points (baseline, 12, 24 months 
follow-up). Additionally, the probability of detecting an effect may have increased had 
we included data from additional time points, such as 36 or 48 months follow-up. 
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However, given the population, participants were at increased risk of mortality as time 
went on; as such, in order to maximize our sample size, we did not extend our data 
mining beyond 24 months follow-up. In regards to study design, our list of indicators to 
operationalize disease severity was not exhaustive, nor were they perfect. However, we 
extrapolated based on the research and included indicators that are strongly linked to AD 
pathology. Finally, we were unable to examine the effect of the nature of the caregiver-
patient relationship as this data was not included in the ADNI dataset. Future research 
should address all of these limitations by utilizing a larger sample with more extensive 
longitudinal follow-up and operationalization of AD severity across multiple measurable 
indicators, such as functional status and neurophysiology. 
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CHAPTER V 
SUMMARY AND CONCLUSIONS 
Results from this study may help us understand the role that caregiver distress 
plays when considering the global impact of AD within a dyad. Understanding the 
reciprocal effects that caregiver distress and AD severity may have on each other has 
many clinical implications.  Identifying patient demographic variables that affect 
caregiver distress, such as age or gender, can help clinicians proactively monitor patients 
who are at risk to elicit increased distress from their caregivers. Furthermore, because 
baseline caregiver distress was found to significantly predict cognitive status over time, 
there may be incentive to treat caregiver distress to indirectly mitigate this aspect of AD 
progression. Additionally, if a feedback loop exists wherein caregiver distress 
contributes to future AD severity, which in turn causes increased caregiver distress, this 
preliminary study may facilitate future research into this cyclical model of the 
distress/severity relationship. Consequently, we will have greater understanding of the 
nature of AD pathology, as well as socio-structural risk factors for and protective factors 
against increased disease severity. Finally, identifying groups of caregivers who are 
more likely to experience elevated levels of distress may allow for more tailored 
psychotherapeutic interventions and psychoeducation to reduce caregiver distress and 
improve caregiving outcomes. 
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Table 1a  
 
NPI rating schemas for symptom frequency 
Rating Descriptor Operational Definition 
1 Rarely Less than once a week 
2 Sometimes Roughly once a week 
3 Often Many times a week but less than every day 
4 Very often At least once or more daily 
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Table 1b  
 
NPI rating schemas for symptom severity 
Rating Descriptor Operational Definition 
1 Mild 
Symptom is present but appears harmless and produces 
minimal distress 
2 Moderate Symptom is distressing and disruptive 
3 Severe Symptom is very distressing and extremely disruptive 
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Table 1c 
 
NPI rating schemas for caregiver distress 
Rating Descriptor Operational Definition 
0 Not at all --- 
1 Minimally Symptom causes virtually no change in routine 
2 Mildly 
Symptom causes almost no change in routine but 
minimal time rebudgeting is necessary 
3 Moderately 
Symptom disrupts routine and time rebudgeting is 
necessary 
4 Severely 
Symptom disrupts routine, upsets others, and is a major 
time infringement 
5 
Very severely 
or extremely 
Symptom is very disruptive, a major source of distress 
for others, and requires time usually devoted to other 
people or tasks 
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Table 2 
Correlations between continuous patient demographic variables and baseline caregiver 
distress 
Correlated Variables Pearson’s r Value p-value 
Age x Baseline Caregiver Distress -0.03 0.71 
Education x Baseline Caregiver Distress -0.18 0.01* 
Baseline ADAS-cog x Baseline Caregiver Distress 0.21 0.00* 
Baseline Residual Whole Brain Volume x Baseline 
Caregiver Distress 
-0.13 0.07 
Baseline Residual Hippocampus Volume x 
Baseline Caregiver Distress 
-0.10 0.18 
Baseline Residual Entorhinal Cortex Volume x 
Baseline Caregiver Distress 
-0.13 0.08 
Baseline Residual Middle Temporal Gyrus 
Volume x Baseline Caregiver Distress 
-0.04 0.60 
Note: Significant correlations (p < 0.05) designated with an asterisk (*) 
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Table 3 
One-way analysis of variance (ANOVA) results between categorical patient 
demographic variables and baseline caregiver distress 
Variable F p-value 
Patient Gender 1.25 0.27 
Patient Race 2.86 0.04* 
Marital Status 1.05 0.37 
Baseline Diagnosis 11.48 0.00* 
Note: Significant differences between groups (p < 0.05) designated with an asterisk (*) 
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Table 4a 
Hierarchical regression predicting effects of baseline caregiver distress on cognitive 
indicators of AD severity (ADAS-cog score) at 12 months follow-up 
Model R2 ΔR2 F p-value 
1 Sex; Education; Age 0.04 0.04 2.16 0.09 
2 Baseline Diagnosis 0.36 0.33 46.17 0.00 
3 Race 0.38 0.01 1.20 0.31 
4 Marital Status 0.39 0.01 1.09 0.35 
5 Baseline ADAS-cog 0.66 0.27 135.69 0.00 
6 
Baseline residual temporal 
lobe volumes 
0.67 0.01 2.08 0.11 
7 Baseline caregiver distress 0.68 0.01 5.01 0.03* 
Note: Significant model (p < 0.05) designated with an asterisk (*) 
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Table 4b 
Hierarchical regression predicting effects of baseline caregiver distress on cognitive 
indicators of AD severity (ADAS-cog score) at 24 months follow-up 
Model R2 ΔR2 F p-value 
1 Sex; Education; Age 0.05 0.05 2.80 0.04 
2 Baseline Diagnosis 0.34 0.30 40.17 0.00 
3 Race 0.35 0.01 0.88 0.45 
4 Marital Status 0.36 0.01 0.67 0.57 
5 Baseline ADAS-cog 0.65 0.29 139.76 0.00 
6 
Baseline residual temporal 
lobe volumes 
0.68 0.03 5.25 0.00 
7 Baseline caregiver distress 0.69 0.01 5.51 0.02* 
Note: Significant model (p < 0.05) designated with an asterisk (*) 
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Table 4c 
Hierarchical regression predicting effects of baseline caregiver distress on 
neuroanatomical indicators of AD severity (residual MRI volume of the hippocampus) at 
12 months follow-up 
Model R2 ΔR2 F p-value 
1 Sex; Education; Age 0.00 0.00 0.27 0.85 
2 Baseline Diagnosis 0.25 0.25 29.65 0.00 
3 Race 0.25 0.00 0.06 0.98 
4 Marital Status 0.26 0.00 0.18 0.91 
5 Baseline ADAS-cog 0.33 0.06 19.22 0.00 
6 
Baseline residual temporal 
lobe volumes 
0.94 0.61 570.34 0.00 
7 Baseline caregiver distress 0.94 0.00 0.43 0.52 
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Table 4d 
Hierarchical regression predicting effects of baseline caregiver distress on 
neuroanatomical indicators of AD severity (residual MRI volume of the hippocampus) at 
24 months follow-up 
Model R2 ΔR2 F p-value 
1 Sex; Education; Age 0.01 0.01 0.35 0.79 
2 Baseline Diagnosis 0.27 0.27 32.54 0.00 
3 Race 0.28 0.00 0.24 0.87 
4 Marital Status 0.28 0.00 0.26 0.85 
5 Baseline ADAS-cog 0.38 0.10 26.76 0.00 
6 
Baseline residual temporal 
lobe volumes 
0.92 0.55 398.15 0.00 
7 Baseline caregiver distress 0.92 0.00 0.96 0.33 
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Table 4e 
Hierarchical regression predicting effects of baseline caregiver distress on 
neuroanatomical indicators of AD severity (residual MRI volume of the entorhinal 
cortex) at 12 months follow-up 
Model R2 ΔR2 F p-value 
1 Sex; Education; Age 0.03 0.03 1.61 0.19 
2 Baseline Diagnosis 0.17 0.14 15.16 0.00 
3 Race 0.18 0.01 1.03 0.38 
4 Marital Status 0.19 0.01 0.39 0.76 
5 Baseline ADAS-cog 0.27 0.08 19.78 0.00 
6 
Baseline residual temporal 
lobe volumes 
0.84 0.57 198.59 0.00 
7 Baseline caregiver distress 0.84 0.00 0.00 0.96 
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Table 4f 
Hierarchical regression predicting effects of baseline caregiver distress on 
neuroanatomical indicators of AD severity (residual MRI volume of the entorhinal 
cortex) at 24 months follow-up 
Model R2 ΔR2 F p-value 
1 Sex; Education; Age 0.02 0.02 1.50 0.22 
2 Baseline Diagnosis 0.17 0.15 16.16 0.00 
3 Race 0.18 0.00 0.16 0.92 
4 Marital Status 0.18 0.01 0.37 0.78 
5 Baseline ADAS-cog 0.27 0.09 20.10 0.00 
6 
Baseline residual temporal 
lobe volumes 
0.80 0.54 153.66 0.00 
7 Baseline caregiver distress 0.81 0.00 0.75 0.39 
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Table 4g 
Hierarchical regression predicting effects of baseline caregiver distress on 
neuroanatomical indicators of AD severity (residual MRI volume of the middle temporal 
gyrus) at 12 months follow-up 
Model R2 ΔR2 F p-value 
1 Sex; Education; Age 0.00 0.00 0.06 0.98 
2 Baseline Diagnosis 0.10 0.09 9.30 0.00 
3 Race 0.10 0.01 0.51 0.67 
4 Marital Status 0.11 0.01 0.70 0.55 
5 Baseline ADAS-cog 0.19 0.07 14.92 0.00 
6 
Baseline residual temporal 
lobe volumes 
0.92 0.74 544.04 0.00 
7 Baseline caregiver distress 0.92 0.00 0.06 0.81 
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Table 4h 
Hierarchical regression predicting effects of baseline caregiver distress on 
neuroanatomical indicators of AD severity (residual MRI volume of the middle temporal 
gyrus) at 24 months follow-up 
Model R2 ΔR2 F p-value 
1 Sex; Education; Age 0.01 0.01 0.28 0.84 
2 Baseline Diagnosis 0.13 0.12 12.57 0.00 
3 Race 0.13 0.01 0.43 0.73 
4 Marital Status 0.14 0.01 0.65 0.59 
5 Baseline ADAS-cog 0.23 0.09 18.83 0.00 
6 
Baseline residual temporal 
lobe volumes 
0.90 0.67 374.31 0.00 
7 Baseline caregiver distress 0.90 0.00 0.52 0.47 
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Table 4i 
Hierarchical regression predicting effects of baseline caregiver distress on 
neuroanatomical indicators of AD severity (residual MRI volume of the whole brain) at 
12 months follow-up 
Model R2 ΔR2 F p-value 
1 Sex; Education; Age 0.02 0.02 1.12 0.34 
2 Baseline Diagnosis 0.04 0.02 1.94 0.15 
3 Race 0.06 0.02 1.39 0.25 
4 Marital Status 0.08 0.02 0.93 0.43 
5 Baseline ADAS-cog 0.11 0.04 6.71 0.01 
6 
Baseline residual whole brain 
volume 
0.98 0.87 7629.03 0.00 
7 Baseline caregiver distress 0.98 0.00 0.05 0.82 
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Table 4j 
Hierarchical regression predicting effects of baseline caregiver distress on 
neuroanatomical indicators of AD severity (residual MRI volume of the whole brain) at 
24 months follow-up 
Model R2 ΔR2 F p-value 
1 Sex; Education; Age 0.02 0.02 1.16 0.33 
2 Baseline Diagnosis 0.05 0.03 2.77 0.07 
3 Race 0.07 0.02 1.10 0.35 
4 Marital Status 0.09 0.02 1.17 0.32 
5 Baseline ADAS-cog 0.13 0.05 9.68 0.00 
6 
Baseline residual whole brain 
volume 
0.97 0.83 4185.45 0.00 
7 Baseline caregiver distress 0.97 0.00 1.41 0.24 
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Figure 1 
Hierarchical regression examining downstream effects of baseline caregiver distress on 
future AD severity 
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Figure 2 
Outcome variable changes in each model to reflect the selected indicators of AD severity 
(cognitive impairment and neurodegeneration) 
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Figure 3 
Replication of the third and final step of the hierarchical regression to reflect outcome 
data from 12 and 24 months follow-up 
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Figure 4 
Seventh and final steps for each of the eight main regression models reflecting different 
indicators of disease severity and time points 
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Figure 5 
Marginal means of total NPI score from baseline through 24 months follow-up 
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Figure 6a 
Frequency of symptom endorsement by caregivers from baseline through 12 and 24 
months follow up (grouped by time point) 
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Figure 6b 
Frequency of symptom endorsement by caregivers from baseline through 12 and 24 
months follow up (grouped by symptom) 
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Figure 7a  
Mean symptom severity ratings from baseline through 12 and 24 months follow-up 
(grouped by time point) 
 
Number of ratings assessed for each symptom at each time point (n) 
Symptom Baseline 12 months 24 months 
Elation/Euphoria 2 2 6 
Aberrant Motor Behavior 5 5 13 
Depression/Dysphoria 36 36 38 
Disinhibition 13 12 11 
Anxiety 23 25 20 
Irritability/Lability 34 37 42 
Apathy/Indifference 24 30 36 
Agitation/Aggression 16 24 30 
Sleep Disturbance 32 36 34 
Appetite 15 17 25 
Hallucinations 1 2 7 
Delusions 2 7 10 
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Figure 7b  
Mean symptom severity ratings from baseline through 12 and 24 months follow-up 
(grouped by symptom)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Number of ratings assessed for each symptom at each time point (n) 
Symptom Baseline 12 months 24 months 
Elation/Euphoria 2 2 6 
Aberrant Motor Behavior 5 5 13 
Depression/Dysphoria 36 36 38 
Disinhibition 13 12 11 
Anxiety 23 25 20 
Irritability/Lability 34 37 42 
Apathy/Indifference 24 30 36 
Agitation/Aggression 16 24 30 
Sleep Disturbance 32 36 34 
Appetite 15 17 25 
Hallucinations 1 2 7 
Delusions 2 7 10 
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Figure 8a  
Mean caregiver distress ratings per symptom from baseline through 12 and 24 months 
follow-up (grouped by time point) 
 
Number of ratings assessed for each symptom at each time point (n) 
Symptom Baseline 12 months 24 months 
Hallucinations 0 1 6 
Elation/Euphoria 2 2 5 
Aberrant Motor Behavior 4 4 9 
Depression/Dysphoria 32 33 37 
Delusions 2 7 9 
Anxiety 22 23 19 
Apathy/Indifference 23 28 34 
Agitation/Aggression 15 22 26 
Irritability/Lability 30 35 38 
Appetite 14 10 19 
Disinhibition 11 12 11 
Sleep Disturbance 22 21 20 
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Figure 8b 
Mean caregiver distress ratings per symptom from baseline through 12 and 24 months 
follow-up (grouped by symptom) 
 
Number of ratings assessed for each symptom at each time point (n) 
Symptom Baseline 12 months 24 months 
Hallucinations 0 1 6 
Elation/Euphoria 2 2 5 
Aberrant Motor Behavior 4 4 9 
Depression/Dysphoria 32 33 37 
Delusions 2 7 9 
Anxiety 22 23 19 
Apathy/Indifference 23 28 34 
Agitation/Aggression 15 22 26 
Irritability/Lability 30 35 38 
Appetite 14 10 19 
Disinhibition 11 12 11 
Sleep Disturbance 22 21 20 
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Figure 9 
Marginal means of mean total NPI distress score from baseline through 24 months 
follow-up 
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